Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Metformin and exercise in type 2 diabetes: examining treatment modality interactions.

Boulé NG, Robert C, Bell GJ, Johnson ST, Bell RC, Lewanczuk RZ, Gabr RQ, Brocks DR.

Diabetes Care. 2011 Jul;34(7):1469-74. doi: 10.2337/dc10-2207. Epub 2011 May 20.

PMID:
21602430
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.

Abbasi F, Kamath V, Rizvi AA, Carantoni M, Chen YD, Reaven GM.

Diabetes Care. 1997 Dec;20(12):1863-9.

PMID:
9405908
[PubMed - indexed for MEDLINE]
3.

Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.

Cuthbertson J, Patterson S, O'Harte FP, Bell PM.

Metabolism. 2011 Jan;60(1):52-6. doi: 10.1016/j.metabol.2010.01.001. Epub 2010 Feb 11.

PMID:
20152998
[PubMed - indexed for MEDLINE]
4.

The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.

Robinson AC, Burke J, Robinson S, Johnston DG, Elkeles RS.

Diabetes Care. 1998 May;21(5):701-5.

PMID:
9589227
[PubMed - indexed for MEDLINE]
5.

Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.

Brazg R, Xu L, Dalla Man C, Cobelli C, Thomas K, Stein PP.

Diabetes Obes Metab. 2007 Mar;9(2):186-93.

PMID:
17300594
[PubMed - indexed for MEDLINE]
6.

Comparative effects of glibenclamide and metformin on ambulatory blood pressure and cardiovascular reactivity in NIDDM.

Sundaresan P, Lykos D, Daher A, Diamond T, Morris R, Howes LG.

Diabetes Care. 1997 May;20(5):692-7.

PMID:
9135928
[PubMed - indexed for MEDLINE]
7.

Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.

Cunha MR, Silva ME, Machado HA, Fukui RT, Correia MR, Santos RF, Wajchenberg BL, Rocha DM, Rondon MU, Negrão CE, Ursich MJ.

Diabetes Obes Metab. 2008 Mar;10(3):238-45. doi: 10.1111/j.1463-1326.2006.00690.x.

PMID:
18269639
[PubMed - indexed for MEDLINE]
8.

Combination treatment with ipragliflozin and metformin: a randomized, double-blind, placebo-controlled study in patients with type 2 diabetes mellitus.

Veltkamp SA, van Dijk J, Collins C, van Bruijnsvoort M, Kadokura T, Smulders RA.

Clin Ther. 2012 Aug;34(8):1761-71. doi: 10.1016/j.clinthera.2012.06.027. Epub 2012 Jul 15.

PMID:
22795925
[PubMed - indexed for MEDLINE]
9.

A comparison of preconstituted, fixed combinations of low-dose glyburide plus metformin versus high-dose glyburide alone in the treatment of type 2 diabetic patients.

Erle G, Lovise S, Stocchiero C, Lora L, Coppini A, Marchetti P, Merante D.

Acta Diabetol. 1999 Jun;36(1-2):61-5.

PMID:
10436254
[PubMed - indexed for MEDLINE]
10.

Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes.

Garber AJ, Larsen J, Schneider SH, Piper BA, Henry D; Glyburide/Metformin Initial Therapy Study Group.

Diabetes Obes Metab. 2002 May;4(3):201-8. Erratum in: Diabetes Obes Metab. 2002 Jul;4(4):286..

PMID:
12047399
[PubMed - indexed for MEDLINE]
11.
12.

Metformin and exercise: no additive effect on blood lactate levels in health volunteers.

Gudat U, Convent G, Heinemann L.

Diabet Med. 1997 Feb;14(2):138-42.

PMID:
9047091
[PubMed - indexed for MEDLINE]
13.

The effects of metformin and glibenclamide on glucose metabolism, counter-regulatory hormones and cardiovascular responses in women with Type 2 diabetes during exercise of moderate intensity.

Cunha MR, da Silva ME, Machado HA, Fukui RT, Correa MR, Santos RF, Wajchenberg BL, Rondon MU, Negrão CE, Ursich MJ.

Diabet Med. 2007 Jun;24(6):592-9. Epub 2007 Mar 22.

PMID:
17381497
[PubMed - indexed for MEDLINE]
14.

Acute effect of metformin on exercise capacity in active males.

Johnson ST, Robert C, Bell GJ, Bell RC, Lewanczuk RZ, Boulé NG.

Diabetes Obes Metab. 2008 Sep;10(9):747-54. Epub 2007 Oct 26.

PMID:
17970761
[PubMed - indexed for MEDLINE]
15.

Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.

Horton ES, Clinkingbeard C, Gatlin M, Foley J, Mallows S, Shen S.

Diabetes Care. 2000 Nov;23(11):1660-5.

PMID:
11092289
[PubMed - indexed for MEDLINE]
Free Article
16.

Metformin increases plasma ghrelin in Type 2 diabetes.

Doogue MP, Begg EJ, Moore MP, Lunt H, Pemberton CJ, Zhang M.

Br J Clin Pharmacol. 2009 Dec;68(6):875-82. doi: 10.1111/j.1365-2125.2009.03372.x.

PMID:
20002081
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.

Bays HE, Goldberg RB, Truitt KE, Jones MR.

Arch Intern Med. 2008 Oct 13;168(18):1975-83. doi: 10.1001/archinte.168.18.1975.

PMID:
18852398
[PubMed - indexed for MEDLINE]
18.

Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetes.

Zander M, Taskiran M, Toft-Nielsen MB, Madsbad S, Holst JJ.

Diabetes Care. 2001 Apr;24(4):720-5.

PMID:
11315837
[PubMed - indexed for MEDLINE]
19.

Interaction of sulfonylureas and exercise on glucose homeostasis in type 2 diabetic patients.

Larsen JJ, Dela F, Madsbad S, Vibe-Petersen J, Galbo H.

Diabetes Care. 1999 Oct;22(10):1647-54.

PMID:
10526729
[PubMed - indexed for MEDLINE]
Free Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk